Skip to main content
. 2022 Nov 17;16:3811–3819. doi: 10.2147/OPTH.S385352

Table 3.

Retropupillary versus Anterior Iris-Claw IOL in Marfan’s Syndrome

Variables Posterior “Retropupillary” Artisan (%) Anterior Artisan (%) P-value
Age (years) 24.8 ± 5.2 16.9 ± 3.6 NS
Side of procedure (laterality)
 Right (OD) 2 (40.0) 7 (53.8) NS
 Left (OS) 3 (60.0) 6 (46.2)
Associated ocular diseases 0 (0.0) 0 (0.0) NS
Associated ocular procedure (during artisan implantation:
Peripheral iridotomy 2 (40.0) 11 (91.8) 0.02
Pars plana vitrectomy 14 (23.0) 19 (17.3) NS
Anterior vitrectomy 27 (44.3) 55 (50.0) NS
Postoperative complications
Irregular iris shape 0 (0) 5 (38.5) NS
Iris atrophy 1 (20.0) 4 (30.8) NS
Disenclavation of the haptics (either traumatic or spontaneous) 0 (0) 6 (46.2) NS
Signs of corneal endothelium loss 0 (0.0) 0 (0.0) NS
Pigment dispersion 0 (0.0) 1 (7.7) NS
Postoperative high IOP and/or use of new antiglaucoma and/or glaucoma surgery 1 (20.0) 1 (7.7) NS
Retinal detachment 0 (0.0) 0 (0.0) NS
Epiretinal membrane proliferation 0 (0.0) 0 (0.0) NS
Macular edema 0 (0.0) 0 (0.0) NS
Endophthalmitis/keratitis 0 (0.0) 0 (0.0) NS
Overall visual outcome
Change in BCVA at 1 week postoperative (LogMAR) −0.425 ± 0.1 −0.114 ± 0.08 NS
Change in BCVA at 1 month postoperative (LogMAR) −0.667 ± 0.1 −0.317 ± 0.09 NS
Change in BCVA at 1 year postoperative (LogMAR) −0.600± 0.2 −0.357 ± 0.2 NS
Change in BCVA at last follow up (LogMAR) −0.640 ± 0.1 −0.346 ± 0.1 NS

Abbreviations: SEM, standard error of the mean; OD, right eye; OS, left eye; IOL, intraocular lens; BCVA, best corrected visual acuity; IOP, intraocular pressure; NS, not significant.